In MCF-7 breast cancer cells, silencing the PADI4 gene led to a significant decrease in the nuclear GSK3β level, activation of TGF-β signaling, and induction of the EMT by decreasing E-cadherin and increasing vimentin expression, resulting in more aggressive tumor cells [89]. This evidence concerns the gene PADI4 and breast carcinoma.